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Abstract
Intraoperative assessment of surgical margins remains one of the main chal-
lenges in cancer surgery. Raman spectroscopy can detect cancer cells with high
accuracy, but it is time-consuming. In this paper, we investigated a selective-
sampling Raman spectroscopy approach, based on high wavenumber
(HW) Raman imaging (spectral range 2,500–3,500 cm−1) and fingerprint
Raman spectroscopy (spectral range 600–1,800 cm−1), to reduce the overall tis-
sue analysis time while maintaining high diagnostic accuracy. HW Raman
mapping was used as a first step to identify the adipose tissue regions based on
the C–H stretching bands at 2,700–2,950 cm−1. As residual tumors are typically
found in nonadipose tissue, an algorithm was developed to allocate sampling
points for fingerprint Raman spectroscopy at locations corresponding to low
intensity in the HW-Raman maps. Preliminary results show that HW-Raman
imaging based on a 671 nm laser is effective and fast for mapping of adipose
tissue in breast resections, with typical imaging times of 2 min for tissue areas
as large as 2 × 2 cm2 areas. Albeit the remaining high fluorescence background
in the fingerprint region prevents the use of single 671-nm laser, the HW
Raman imaging can be still exploited in combination with 785-nm excitation
Raman spectroscopy for identifying residual tumor. Although this study dem-
onstrates the feasibility of this approach, further improvements, such as using
single element detectors for HW Raman imaging, are required to increase the
analysis speed further towards intraoperative use in the routine clinical
setting.
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1 | INTRODUCTION
Breast conserving surgery (BCS) is widely used for
treating patients with breast cancers.[1] The main aim of
surgery is to remove the tumor while conserving
surrounding healthy tissue. The completeness of tumor
resection is usually confirmed postoperatively by histo-
pathological examination of fixed tissue. Intraoperative
assessment of margins can save up to 40% of BCS patients
a second surgical intervention by providing information
real-time information to surgeons on whether the entire
tumor has been excised or not. Although frozen sections
examination can be helpful, it is very challenging to
examine the whole surface area of the excised margin
and is becoming less common due to availability of
pathologists. Current intraoperative imaging of the
surgical specimen can help surgeons to excise further
tissue. However, the available imaging modalities rely on
simple X-rays which lack accuracy. Reports indicate
that in about 20% of cases histology detects positive
margins, and additional surgeries are required to
achieve complete excision.[2,3] There is a need for an
accurate and fast tool for intraoperative assessment of
surgical margin to aid surgeons in achieving complete
resection.
Raman spectroscopy is a highly sensitive optical tech-
nique that can be used to measure the molecular compo-
sition of tissue without requiring labelling or other
contrast enhancing agents.[4] The developments in
Raman spectroscopy for intraoperative assessment of sur-
gical margins in cancer surgery have been recently
reviewed.[5] Different modalities of Raman spectroscopy,
operating in the fingerprint region (600–1,800 cm−1),
have been reported in the literature for the assessment of
breast specimens, reporting sensitivity and specificity typ-
ically higher than 90%,[6] including handheld fiber probes
for in vivo point measurements[7,8] and spatially offset
Raman spectroscopy (SORS) for detection of positive
margins in unsectioned breast resections.[9,10] However,
these handheld probes are operator-dependent and can
miss small residual tumors (e.g., ductal carcinoma in
situ). Raster-scanning imaging based on spontaneous
Raman microscopy has the spatial accuracy and molecu-
lar specificity needed but requires long acquisition times,
making this technique impractical for intraoperative use.
One approach for reducing the acquisition time is
surface-enhanced Raman spectroscopy (SERS), where the
speed of imaging significantly boosted by the signal
enhancement. Kang et al[11] demonstrated detection of
tumor on the excision surface with 89% sensitivity and
92% specificity by using gold nanoparticles functionalized
with reporter SERS labels and monoclonal antibodies
targeting specific biomarkers.
An alternative approach to reduce analysis time is
selective-sampling Raman spectroscopy, which uses spa-
tial information of the sample to guide Raman spectros-
copy to the regions more likely to contain tumor, thus
reducing the overall number of Raman
measurements.[12–16] This approach has the advantage
that no exogenous labels are required, making it poten-
tially simpler for clinical use. In a previous study, we
developed a selective-sampling technique that combined
high-resolution wide-field auto-fluorescence (AF) microscopy
and fingerprint Raman spectroscopy (700–1,800 cm−1 Raman
shift region) to detect ductal carcinomas in frozen breast
microsections (5 × 5 mm2).[14] More recently, confocal AF-
Raman spectroscopy combined with more efficient data
processing algorithms enabled the analysis of larger tissues
areas (4 × 6.5 cm2 area) with acquisition times of 12–24 min,
achieving 95% sensitivity and 82% specificity in an indepen-
dent test on 121 samples from 107 patients (including
51 fresh, whole excision specimens).[17] Although the confo-
cal AF was effective in segmenting the tissue images based
on AF intensity, it was not able to reliably identify the
regions of adipose tissue. As most of the surface area of
breast excision specimens is composed of adipose tissue, a
large number of Raman fingerprint spectra were from adi-
pose tissue areas, increasing analysis time, even though these
rarely contain tumor.
In this study, we propose an improved method for
analyzing the margins of breast resection specimens by
using the high-wavenumber (HW) (2,700–3,500 cm−1)
and fingerprint Raman spectral regions. The confocal AF
imaging was replaced by HW Raman mapping to detect
adipose tissue based on the lipid bands at the
2,800–3,100 cm−1. HW Raman spectroscopy has been
proposed for fast tumor diagnosis in head-and-neck
cancer.[18–20] Here, HW is used only for screening out
adipose tissue, and the final diagnosis is then performed
using fingerprint Raman spectroscopy measurements at
the remaining non-adipose tissue areas. This approach
has the advantage of targeting the fingerprint Raman
measurements more effectively to the nonadipose tissue
areas, which are associated with stroma, benign, or
malignant tumor.
2 | METHODS
2.1 | Tissue samples
Breast tissue blocks with sizes in the ranges 4 × 6 mm2 to
20 × 20 mm2 (thickness of 2 mm) were cut from breast
resection during mastectomy and stored at –20C.
Although surgical practice involved injection of blue dye
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in subareolar region in order to aid the identification of
sentinel lymph nodes, no dye was detected at the margin
of the wide local excision. Prior to Raman spectroscopy
experiments, samples were thawed at room temperature.
Ethical approval was granted through the Nottingham
Health Science Biobank (NHSB, REC reference
15/NW/0685), and informed consent was obtained from
all patients.
2.2 | Instrumentation
A schematic description of the instrument is presented in
Figure 1. A 2-axis scanning galvo-mirror system
(GVS012/M, Thorlabs) was coupled to an inverted optical
microscope (Nikon Eclipse). A 671-nm wavelength CW
laser with maximum power of 250 mW (Gem
671, LaserQuantum) was used for excitation of Raman
scattering. A silicon-based CCD detector (Andor Newton
920 BR-DD, Oxford Instruments) attached to a spectrom-
eter (grating blazed for 750 nm, 75% peak efficiency) was
used for detection of Raman scattered light. A 2× micro-
scope objective (Nikon Plan Apo 2×/0.1 NA) was used for
fast HW Raman spectral imaging to cover a large field of
view. The fingerprint Raman spectra were acquired with
a high NA 63× oil-immersion objective (RiverD 63×
oil/1.2 NA). The scanning area for the galvo-mirror sys-
tem with the 2× objective was 7 × 7 mm2 on the sample
plane. A translation stage was used to move the sample
to achieve larger scanning area covering the entire tissue
samples. Scanning tiles were stitched in postprocessing to
produce full HW Raman maps of tissue.
Custom-written LabVIEW (National Instruments)
software was developed to control the galvo scanners and
the microscope translational stage. To achieve high-speed
spectral imaging, the program was used in combination
with Andor Solis software for data acquisition. A DAQ
card (USB-1808X, Measurement Computing) was used to
synchronize the movement of the galvo-mirror scanners
and for triggering the CCD camera. The acquired data
were then processed and analyzed in MATLAB
(MathWorks).
3 | RESULTS AND DISCUSSION
3.1 | Instrument optimization and
validation
First, different laser wavelengths were evaluated with
wavelengths in the visible and NIR regions, to identify
the optimal wavelength that may provide efficient excita-
tion of Raman scattering in both fingerprint and high-
wavenumber regions, while minimizing the excitation of
fluorescence emissions. Although shorter wavelengths (λ)
are more advantageous for increasing scattering effi-
ciency (intensity λ−4) and matching better the spectral
response of the silicon CCDs, they can excite fluorescence
emission. On the other hand, longer laser wavelengths
minimize laser-induced fluorescence emission, but the
scattering efficiency is lower, and the CCD will have
lower quantum efficiencies. Figure 2 shows Raman spec-
tra of breast tissues, including samples containing both
adipose and non-adipose tissue, recorded using three
common laser wavelengths: 532, 660, and 785 nm.
The results in Figure 2 show that for 532-nm excita-
tion, the fluorescence background generated by the laser-
induced excitation is very high compared to the Raman
bands, causing significant distortions or even swamping
the Raman bands. For adipose tissue, the CH bands at
2,850–3,010 cm−1 in the HW region[6] are detectable, but
the signal is on similar scale with the fluorescence back-
ground. The fluorescence background is even stronger for
nonadipose tissue, and only the broad water band is
detectable at 3,400 cm−1.19 In the fingerprint region,
only the bands at 1,157 and 1,525 cm−1 can be detected
FIGURE 1 Schematic of 2D-galvo-mirror
laser scanning system for fast high-wavenumber
(HW) Raman imaging and fingerprint Raman
spectroscopy using a single 671-nm laser. M1,
M2, M3, M4, mirrors; DM, dichroic mirror; L1,
L2, lenses
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for the adipose tissue, which can be assigned to caroten-
oids.[21] For the 660-nm laser excitation, the fluorescence
background was significantly reduced and more likely to
be caused by light scattering and stray light. The Raman
bands are detectable both in the high-wavenumber and
fingerprint regions for both adipose and nonadipose
breast tissue. In particular, the HW spectra of adipose tis-
sue show intense bands in the 2,700–3,000 cm−1 region
assigned to CH2 and CH3 stretching vibrations. On the
other hand, the nonadipose tissue has more intense
Raman band in the 3,000–3,550 cm−1 region assigned to
water stretching vibrations. When the excitation wave-
length increases to 785 nm, the background is further
reduced, but the Raman bands in the HW region
(corresponding to 1,000–1,100 nm) are hardly detectable
as the efficiency of the silicon-based CCD detector drops
below 30% beyond 1,000 nm. These results indicate that
the selection of laser excitation around 660 nm is a good
trade-off between maximizing the efficiency for detecting
the Raman bands in both fingerprint and the high
wavenumber regions and enables discrimination between
the adipose and nonadipose tissue. Based on this conclu-
sion, an integrated Raman microscope with a 671-nm
laser was developed for all other experiments presented
here (671 nm was selected over 660 nm based on avail-
ability, laser power, and cost).
FIGURE 2 Fingerprint and high-wavenumber Raman spectra of breast tissue acquired from adipose tissue and nonadipose tissue
(in this case breast tumor). Tumor show strong broad band of O–H in the high-wavenumber region (3,100–3,550 cm−1) due to high water
content. Adipose tissue presents much lower level of O–H band, but significant stronger lipid bands (2,800–3,100 cm−1)
FIGURE 3 (a) Bright field image of PS and
stilbene particles. Scale bar: 2 mm. (b) Typical
HW-Raman spectra of PS and stilbene obtained
during the imaging process; integration time
10 ms/pixel. (c) HW Raman image of the
particles shown in (a), constructed using the
Raman band at 3,000 cm−1. (d) Fingerprint
Raman spectra of PS and stilbene acquired by
selecting sampling points based on the HW-
Raman map presented in (c)
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To maximize the speed for acquiring the HW Raman
spectral maps, the field of view was maximized by using
a 2× objective (trade-off between field of view and signal
strength, which is determined by the numerical aperture
of the objective). However, for measuring the Raman
spectra in the fingerprint region, the microscope objective
was changed to a 63×/NA = 1.2 oil immersion objective
optimized for the 650–1,000 nm spectral region. To test
the calibration of the instrument when switching
between objectives and ensure that the high-wavenumber
Raman maps can be used to select regions of the samples
that can then be relocated when changing to the higher
NA objective, a sample consisting of polystyrene and stil-
bene particles was used (size of particles 2 mm)
(Figure 3a). Typical HW Raman spectra of PS and stil-
bene are shown in Figure 3b, indicating a strong band at
3,000 cm−1 assigned to C–H stretching vibrations.
Figure 3c presents the HW Raman map obtained by inte-
grating the Raman band at 3,000 cm−1 after background
subtraction (the gray lines in Figure 3b indicate the cubic
polynomial fittings for background subtraction). The
HW-Raman map was acquired at a resolution of
150 × 150 pixels (step size 140 μm), then resized to
9,000 × 9,000 pixels to match the bright field image for
calibration. Using the coordinates from the HW Raman
map, several particles were selected for measurements of
fingerprint Raman spectra (the microscope objective was
then changed). Figure 3d shows that the fingerprint
Raman spectra acquired at the selected locations agreed
with the particle type (polystyrene or stilbene), demon-
strating that the relocation accuracy between the HW
Raman map and fingerprint Raman measurements is
precise within 100 μm, which is sufficient for the purpose
of this study.
3.2 | HW Raman mapping of adipose
tissue
The optimal parameters for acquiring the HW Raman
maps using tissue samples that contained a mixture of
adipose and nonadipose tissue were investigated. For
convenience, first, we used porcine tissue (abdomen
region) from a local supermarket. Figure 4 presents HW
Raman maps acquired using a range of acquisition dwell
times and spatial steps of 230 μm. The selection of the
step size was a trade-off between imaging speed and the
resolution needed for the clinical application. In this
case, the latter is set by considering the smallest types of
tumor that need to be detected such as tiny foci of ductal
carcinoma in-situ, or a focus of micro invasive carcinoma
which are typically less than 1 mm2 in size. The HW
Raman images are constructed by integrating the Raman
band at 2,800–3,000 cm−1(assigned to C–H2 and C–H3
symmetric/asymmetric stretching vibrations) after back-
ground subtraction and stitching together multiple
FIGURE 4 HW Raman spectral imaging of
pork tissue with different integration times.
(a) Bright field image. Scale bar: 4 mm. (b) HW-
Raman image with integration time of
10 ms/pixel. Original acquisition size: 90 × 90
pixels, resized to 9,000 × 9,000 pixels.
(c) Integration time: 5 ms/pixel. (d) Integration
time: 2 ms/pixel
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scanning tiles (3 × 3). Figure 4d shows that the adipose
tissue can be identified in the HW Raman maps (bright
areas) even for dwell times as short as 2 ms/pixel, when
laser power of 180 mW (at the sample) was used to
acquire the spectra. Due to the short dwell time per pixel
and low magnification objective, the tissue did not show
any evident damage after measurement. Meanwhile,
because of the short response time of the galvo-mirrors
(400 μs) and high readout rate of the CCD camera
(1 MHz/pixel setting and full vertical binning read-out
mode), the actual acquisition time was less than 3 min
for the entire map, at an integration time of 10 ms per
pixel (Figure 4b).
After optimizing the parameters for mapping of
adipose tissue from the porcine samples, these parame-
ters were checked using human breast tissue samples.
Figure 5 shows HW-Raman images of six breast tissue
samples acquired with integration time of 10 ms per
pixel, along with the H&E images for comparison.
Similar to the images shown in Figure 4, the HW-
Raman images were constructed by integrating the
Raman band at 2,800–3,000 cm−1 (assigned to C–H2
and C–H3 symmetric/asymmetric stretching) after
background subtraction and stitching together multiple
scanning tiles (3 × 3). By comparing the HW-Raman
images and the corresponding H&E images in
Figure 5a–f, the adipose tissues in the breast samples
matched well the high-intensity regions in the HW-
Raman images. The green circles in Figure 5a–d mark
the adipose tissue area in the heterogeneous breast
samples (samples contain also other tissue types),
whereas in Figure 5e,f correspond to samples con-
taining only adipose tissue. The acquisition time for
each of these HW-Raman images (21 × 21 mm2)
was only about 3 min, indicating the potential of the
HW-Raman imaging system using galvo-mirrors for
fast mapping of adipose tissue for human breast
samples.
FIGURE 5 (a–f) HW-Raman
images of breast tissues (intensity
scale: 0–255). H&E images are
shown on the right for comparison.
Scale bars: 4 mm; (g) HW-Raman
spectra of tumor and adipose tissue
from the points shown in (a) and (f),
sum of 10 pixels; insert graph shows
the spectra of adipose tissue after
background subtraction
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For validation, Figure 5g presents two typical raw
Raman spectra in the HW region of nonadipose (red square
in Figure 5a) and adipose tissue (red dot in Figure 5f)
acquired by the spectral imaging system. The spectra con-
firm the presence of the CH2 band in the region of adipose
tissue but not in the tumor region. The water band at
3,100–3,550 cm−1 cannot be identified, mainly because of
the lower intensity and perhaps because the tissue samples
were stored in at −20C (more than a year) prior to the
measurement.
3.3 | Integrated HW imaging—
Fingerprint Raman spectroscopy for fast
analysis of breast tissue
We showed previously[17] that selective-sampling tech-
niques based on intensity threshold segmentation of
auto-fluorescence (AF) images and fingerprint Raman
spectroscopy measurements are a viable approach for
detection of residual tumor in breast resections. This
approach minimized the number of fingerprint Raman
measurements to achieve faster diagnosis (20–30 min)
compared to raster-scanning Raman microscopy (1–2 days).
However, one limitation of the AF imaging was that a large
number of sampling points for fingerprint Raman spectros-
copy were generated in regions of adipose tissue, which is
known not to contain tumor. We optimized these algo-
rithms using the HW-Raman images instead of the AF
image. HW-Raman has high specificity to adipose tissue, as
shown in Figures 4 and 5. As the intensity of the CH2/CH3
Raman bands is higher in adipose tissue compared to
nonadipose tissue, an intensity threshold can be used to
retain only the nonadipose tissue regions and then assign
sampling points for fingerprint Raman measurements in
these regions only. A typical example is shown Figure 6,
which is a breast sample containing tumor and adipose tis-
sue. The HW-Raman image was generated using the
acquired HW Raman spectra and saved as an intensity
image with scale of 0–255. By comparing the images with
the H&E section, the bright and dark regions in the HW-
Raman map correspond to adipose tissue and tumor,
respectively. Figure 6c–f shows the generated segments
using different intensity threshold values, where the regions
of tissue with values higher than the threshold were
labelled as adipose tissue, and the areas with values smaller
than that threshold as “potential tumor” regions. By com-
paring the segments in Figure 6c–f to the H&E image, a
threshold of 120 was considered sufficient for screening out
the adipose tissue and generating sampling points for fin-
gerprint Raman measurements in the “potential tumor”
areas. Sampling points for Raman measurements were then
generated in the “potential tumor” regions with five points
distributed equally in the segments. Previous study[16] has
indicated that five samplings per segment are adequate for
basal cell carcinoma diagnosis in skin tissue. Certainly, the
number of points can be increased if needed for improving
accuracy of diagnosis.
We have then investigated the feasibility of combin-
ing HW-Raman imaging and fingerprint Raman spectros-
copy for fast tumor diagnosis using a single excitation
laser. Results in Figure 2 suggested that 671-nm excita-
tion is sufficient to avoid tissue auto-fluorescence in the
HW-Raman region while taking good advantage of
silicon-based detector in the spectral range of
700–900 nm. The next step was to test if 671-nm excita-
tion is suitable for acquiring Raman spectra in the finger-
print region and discriminating between tumor and other
nonadipose tissue structures in breast tissue
(e.g., stroma). This was implemented using the segmenta-
tion algorithms based on intensity-threshold of HW-
Raman maps. Figure 7 presents a typical example for a
FIGURE 6 HW-Raman imaging
and segmentation of breast tumor tissue
for selective sampling fingerprint
Raman spectroscopy. (a) HW-Raman
image (size 2 × 2 cm2); (b) H&E image;
(c–f) segmentation of the HW-Raman
image with different intensity
thresholds from 100 to 130
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breast tissue sample containing adipose tissue, stroma,
and tumor. The comparison between the HW-Raman
image and H&E section indicates that the segmentation
algorithm was effective in identifying the adipose tissue
and allocating sampling points in the areas of stroma and
tumor. However, the fingerprint Raman spectra mea-
sured at the locations indicated by the sampling points
had large backgrounds, likely caused by laser-induced
fluorescence or scattering/stray light. Selected Raman
spectra, before and after background subtraction, are
FIGURE 7 Multimodal spectral
histopathology diagnosis using high-
wavenumber Raman imaging and selective-
sampling Raman spectroscopy. (a) HW-Raman
image; (b) generated segments and sampling
points. (c) Adjacent H&E image; (d) raw Raman
spectra obtained using 671-nm excitation at
different locations (integration time:
1 s/spectrum); (e) fingerprint Raman spectra
obtained using 671-nm excitation, background
subtracted; (f) fingerprint Raman spectra
obtained using 785-nm excitation (integration
time: 1 s/spectrum)
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reported in Figure 7d,e and show Raman bands at 1,450
and 1,655 cm−1 that can be assigned to the CH2 deforma-
tions and Amide I vibrations in proteins. However,
important bands required for the discrimination of tumor
from other nonadipose tissue structures,[14,17] such as
nucleic acids (788, 1,098, and 1,342 cm−1) and phenylala-
nine (1,004 cm−1), are not distinguishable in the spectra.
Although the initial test results presented in Figure 2b
suggested that lasers with 660 nm wavelength could
effectively avoid auto-fluorescence in the fingerprint
region, the results on a larger number of samples indi-
cated a high level of sample-to-sample variation. For
comparison, fingerprint Raman spectra of the same tissue
samples were also measured using 785-nm laser excita-
tion, and typical spectra of adipose tissue and tumor are
given in Figure 7f. The spectra were collected from
regions of adipose and nonadipose tissue from positions
approximately indicated by the red dots in Figure 7a
(accurate positions are not available as the sample was
moved to another instrument equipped with the 785 nm
laser). In this case, the background was significantly
reduced, and the Raman bands at 1,004, 1,260, and
1,342 cm−1 are well resolved in the spectrum of tumor
whereas the Raman spectra from the adipose tissue have
the typical bands at 1,297 and 1,450 cm−1, assigned to
CH2 and CH vibrations. Although an instrument with a
single laser source would be convenient for simplicity,
this may not be the most efficient approach. The results
suggest that the integration of 671-nm excitation for HW
Raman imaging with 785-nm excitation for the finger-
print Raman spectroscopy would be the most appropriate
for fast diagnosis of breast cancer.
The ultimate goal is to achieve accurate assessment of
whole breast resection specimens within time-scales com-
patible with intraoperative use in breast conserving sur-
gery. The breast samples used in this study were tissues
(4 × 6 mm2 to 20 × 20 mm2) cut from whole BCS speci-
mens. In reality, breast resections can have surface area
larger than 5 × 5 cm2. To map the surface of a large speci-
men with the HW Raman imaging instrument used in
this study would require 15 min. Assuming that 200
fingerprint Raman spectra would be required to diagnose
the regions of nonadipose tissue at the resection surface,
the whole analysis time may be completed in
20–25 min (assuming an integration time of
2–3 s/spectrum to generate a high signal-to-noise ratio
spectrum). It is also worth noting that the instrument can
be further improved to increase the acquisition speed.
The spectrometer and CCD used to acquire HW Raman
spectra, although allowed a better understanding of the
Raman band intensity relative to the background, had a
5 ms as the shortest time limit required for triggering.
Also, when reducing the acquisition times to that level,
the read-out noise of the CCD becomes dominant
(2.5 e−/CCD pixel). Replacing the spectrometer/CCD
with a single-element detector (e.g., photomultiplier
tubes or avalanche photo-diodes) would allow acquisition
times below 1 ms (use a filter to detect all Raman pho-
tons within the 2,700–2,950 cm−1). These improvements
may increase the speed of HW Raman imaging to enable
an overall tissue analysis time of 10 min. If required,
additional higher resolution mapping could be carried
out at the location of the detected tumor in order to accu-
rately determined the edges.
4 | CONCLUSION
In this study, we evaluated the potential use of integrated
high-wavenumber (HW)-Raman imaging and fingerprint
Raman spectroscopy for fast intraoperative assessment of
surgical margins in breast conserving surgery. A laser
scanning Raman imaging system was built using 2D
galvo-mirrors to provide spectral imaging in the HW-
Raman region. The excitation source (671-nm laser)
proved to be suitable to avoid excitation of auto-
fluorescence from breast tissue in the HW region while
effectively making use of the high quantum efficiency of
silicon-based CCDs in the spectral range of 700–900 nm.
Results using human breast tissue demonstrated that
HW-Raman imaging can accurately identify adipose tis-
sue, which then can be effectively screened from further
fingerprint Raman analysis using an intensity-based
threshold segmentation algorithm. However, the patient-
to-patient variations in the laser-induced background
when recording fingerprint Raman spectra, swamping
smaller Raman bands required for discrimination of
tumor from other nonadipose tissue structures in breast
samples. Nevertheless, the auto-fluorescence background
was significantly reduced when a 785-nm laser was used,
guided by the HW-Raman imaging (acquired with
671-nm laser). These results demonstrate the feasibility of
the combined HW Raman imaging and fingerprint
Raman spectroscopy for analyzing whole breast speci-
mens resected during surgery, with estimated analysis
times of 20–25 min. Further improvements, such as using
single element detectors for HW-Raman imaging, may
increase further the analysis speed towards intra-
operative use.
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